BioNTech
Europe, Rheinland-Pfalz, Germany, Mainz
Description
BioNTech is a biopharmaceutical company that develops cancer therapeutics for infectious diseases.
Investor Profile
BioNTech has backed more than 6 startups, with 1 new investments in the last 12 months alone. The firm has led 2 rounds, about 33% of its total and boasts 3 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series Unknown, Post Ipo Equity, Series B rounds (top funding stages).
- Majority of deals are located in United Kingdom, Germany, Poland.
- Strong thematic focus on Biotechnology, Health Care, Therapeutics.
Stage Focus
- Series Unknown (33%)
- Post Ipo Equity (33%)
- Series B (17%)
- Pre Seed (17%)
Country Focus
- United Kingdom (50%)
'%3e%3cpath fill='%23012169' d='M0 0v30h60V0z'/%3e%3cpath stroke='%23fff' stroke-width='6' d='m0 0 60 30m0-30L0 30'/%3e%3cpath stroke='%23C8102E' stroke-width='4' d='m0 0 60 30m0-30L0 30' clip-path='url(%23b)'/%3e%3cpath stroke='%23fff' stroke-width='10' d='M30 0v30M0 15h60'/%3e%3cpath stroke='%23C8102E' stroke-width='6' d='M30 0v30M0 15h60'/%3e%3c/g%3e%3c/svg%3e)
- Germany (33%)
- Poland (17%)
Industry Focus
- Biotechnology
- Health Care
- Therapeutics
- Pharmaceutical
- Medical
- Alternative Protein
- Food And Beverage
- Organic Food
- Sustainability
- Artificial Intelligence (Ai)
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
'/%3e%3cuse xlink:href='%23a' transform='rotate(23.036 .093 25.536)'/%3e%3cuse xlink:href='%23a' transform='rotate(45.87 1.273 16.18)'/%3e%3cuse xlink:href='%23a' transform='rotate(69.945 .996 12.078)'/%3e%3cuse xlink:href='%23a' transform='rotate(20.66 -19.689 31.932)'/%3e%3c/svg%3e)
'/%3e%3cuse xlink:href='%23a' transform='rotate(144 450 300)'/%3e%3cuse xlink:href='%23a' transform='rotate(216 450 300)'/%3e%3cuse xlink:href='%23a' transform='rotate(288 450 300)'/%3e%3c/svg%3e)
